Logo image of ACTD

ARCLIGHT CLEAN TRANSITION -A (ACTD) Stock Fundamental Analysis

NASDAQ:ACTD - Nasdaq - KYG0R21B1044 - Common Stock - Currency: USD

7.6  -0.22 (-2.81%)

After market: 7.95 +0.35 (+4.61%)

Fundamental Rating

3

Taking everything into account, ACTD scores 3 out of 10 in our fundamental rating. ACTD was compared to 0 industry peers in the Unkown industry. The financial health of ACTD is average, but there are quite some concerns on its profitability. ACTD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ACTD had negative earnings in the past year.
ACTD Yearly Net Income VS EBIT VS OCF VS FCFACTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -3.84%
ROE N/A
ROIC -1.57%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACTD Yearly ROA, ROE, ROICACTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 -1 -2 -3 -4 -5

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACTD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACTD Yearly Profit, Operating, Gross MarginsACTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

6

2. Health

2.1 Basic Checks

ACTD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ACTD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACTD Yearly Shares OutstandingACTD Yearly Shares OutstandingYearly Shares Outstanding 2021 10M 20M 30M
ACTD Yearly Total Debt VS Total AssetsACTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 100M 200M 300M

2.2 Solvency

An Altman-Z score of 4.64 indicates that ACTD is not in any danger for bankruptcy at the moment.
ACTD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.64
ROIC/WACC-0.18
WACC8.71%
ACTD Yearly LT Debt VS Equity VS FCFACTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 6.50 indicates that ACTD has no problem at all paying its short term obligations.
A Quick Ratio of 6.50 indicates that ACTD has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.5
Quick Ratio 6.5
ACTD Yearly Current Assets VS Current LiabilitesACTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 500K 1M 1.5M

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1176.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ACTD will show a very strong growth in Earnings Per Share. The EPS will grow by 87.01% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y166.47%
EPS Next 2Y110.48%
EPS Next 3Y75.51%
EPS Next 5Y87.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACTD Yearly Revenue VS EstimatesACTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 1B 2B 3B
ACTD Yearly EPS VS EstimatesACTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

ACTD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 6.37, the valuation of ACTD can be described as very cheap.
ACTD is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.37
ACTD Price Earnings VS Forward Price EarningsACTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACTD Per share dataACTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACTD's earnings are expected to grow with 75.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y110.48%
EPS Next 3Y75.51%

0

5. Dividend

5.1 Amount

ACTD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARCLIGHT CLEAN TRANSITION -A

NASDAQ:ACTD (7/21/2022, 8:00:00 PM)

After market: 7.95 +0.35 (+4.61%)

7.6

-0.22 (-2.81%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-16 2022-05-16/amc
Earnings (Next)N/A N/A
Inst Owners1.05%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap295.60M
Analysts85.71
Price Target20.4 (168.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.37
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)1.19
Fwd EY15.7%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.1
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.84%
ROE N/A
ROCE N/A
ROIC -1.57%
ROICexc N/A
ROICexgc -1.57%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.5
Quick Ratio 6.5
Altman-Z 4.64
F-Score4
WACC8.71%
ROIC/WACC-0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1176.25%
EPS Next Y166.47%
EPS Next 2Y110.48%
EPS Next 3Y75.51%
EPS Next 5Y87.01%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A